Please assess the completion status of the following clinical trial:

Trial Title: Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* acute symptomatic ischemic stroke having relevant lesion on DWI(Diffusion weighted image) MRI 7 days after and 42 days within onset.~* relevant stenosis(more than 50%) or occlusion from MCA(middle cerebral artery)(M1) to distal of ICA(internal carotid artery ) on MR(Magnetic resonance) angiogram or CT angiogram.~* mean systolic blood pressure\>=140mmHg or taking antihypertensive drug on screening.~Exclusion Criteria:~* taking more than 3 antihypertensive drugs and mean systolic blood pressure\>=150mmHg on screening.~* history of recent thrombolysis but stenosis or occlusion remained after thrombolysis.~* evidence of orthostatic hypotension~* suspicious embolic cerebrovascular stenosis~* planned state of cerebrovascular surgery or angioplasty or stent 7 months within screening.~* severe stroke-NIHSS\>=16~* mean systolic blood pressure\>=200mmHg which is not able to control on screening.~* abnormal blood test finding (abnormal LFT(liver function test), anemia, renal insufficiency)~* pregnant or breast-feeding~* severe stroke sequela or medical problem~* suspicious secondary hypertension~* disease causing edema or significant ankle edema on screening.~* severe heart failure which correspond to NYHA (New York Heart Association )heart failure classification class III or IV.~* inappropriate condition determined by investigator~* Patient who do not have FLAIR image on or two months prior to screening.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aggressive BP lowering (Type: EXPERIMENTAL): Lowering of systolic blood pressure between 110mmHg and 120mmHg during study period
- Modest BP lowering (Type: ACTIVE_COMPARATOR): Lowering of systolic blood pressure between 130mmHg and 140mmHg

Based on this trial design, predict the completion outcome and termination type (if applicable).